rosuvastatin/Finding
One finding, on its own
A single claim from the graph, with the grade computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Decreases diastolic blood pressure (setting unspecified)
LikelyGrade B, Likely. Human evidence with one recorded weakness, or capped at B by its design or by unread numbers.Finding“The patients treated with rosuvastatin in addition to antihypertensives had a significantly lower DBP (MD = −2.12 mmHg; 95% CI = −3.72 to −0.52; Pfixed-effects model = 0.009; I 2 = 0%, Pheterogeneity = 0.97) than the patients treated with antihypertensives alone.”
Quoted verbatim from Antihypertensive effects of rosuvastatin in patients with hypertension and dyslipidemia: A systemic review and meta-analysis of randomized studies.. - Study
- meta-analysis
- Duration
- 8 weeks
- Dose
- rosuvastatin 20 mg/day
- Population
- Patients with hypertension and dyslipidemia treated with rosuvastatin 20 mg/day plus antihypertensive agents (an ARB, or an ARB plus a calcium channel blocker), compared with the same antihypertensive background alone
Effect -2.12 mean difference, 95% CI -3.72 to -0.52
Antihypertensive effects of rosuvastatin in patients with hypertension and dyslipidemia: A systemic review and meta-analysis of randomized studies.2021PMID:34818350Permalink
Keep reading
- Everything the graph holds on rosuvastatin
- Every compound studied against Diastolic blood pressure (setting unspecified)
- How to read the grade and the marks
To cite this finding: https://catalystproject.ai/e/01M3PEXHTDEXZED69J2D5V19X7